Table 4.
Organ/system involvement | Group 0 | Group 1 | Group 2 | Group 3 | Group 4 | p value |
---|---|---|---|---|---|---|
Heart disease | 0a | 0.216 | 0.341 | 0.390 | 0.550 | 0.00016 |
Liver disease | 0a | 0.337 | 0.460 | 0.593 | 0.724 | 2.96 × 10−33 |
Pancreas disease | 0a | 0.054 | 0.073 | 0.218 | 0.304 | 7.15 × 10−5 |
Kidney disease | 0a | 0.121 | 0.244 | 0.278 | 0.434 | 0.0117 |
Innate and adaptive immune deficit | 0a | 0.202 | 0.138 | 0.270 | 0.507 | 0.229 |
Olfactory/gustatory deficit | 0,4 | 0.162 | 0.225 | 0.157 | 0.086 | 0.0011 |
Thromboembolism | 0a | 0.040 | 0.073 | 0.097 | 0.318 | 4.2 × 10−7 |
Hyperinflammatory response | NA | 0.081 | 0.152 | 0.278 | 0.492 | 2.02 × 10−5 |
NA not applicable.
aAssigned on clinical ground.